Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-28

Clinical Trial Update: Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2) [Phase 3]

View source ↗

Summary

Phase 3 TRANSACT2 trial reports on treatment efficacy and malaria transmission after artemisinin-based combination therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (artemisinin-based combination therapy)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED